Nephrology: 3. Safe drug prescribing for patients with renal insufficiency.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

1. In which patients should serum creatinine be measured before iodinated contrast medium administration?European radiology · 2005
   Guideline
2. Clinical Pertinence and Determinants of Potential Drug-Drug Interactions in Chronic Kidney Disease Patients: A Cross-sectional Study.The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians · 2024
   Article
3. Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota.Acta pharmaceutica Sinica. B · 2023
   Article
4. Intravenous contrast media in radiation therapy planning computed tomography scans - Current practice in Ireland.Technical innovations & patient support in radiation oncology · 2019
   Article
5. Metronidazole- and levofloxacin-induced psychotic disorders in chronic kidney patient.European journal of hospital pharmacy : science and practice · 2019
   Article
6. Knowledge and awareness of nonpharmacist salespersons regarding over-the-counter drug use in patients with chronic kidney disease in Japan.PloS one · 2019
   Article
7. Medication Safety Principles and Practice in CKD.Clinical journal of the American Society of Nephrology : CJASN · 2018
   Review
8. Clinical relevancy and determinants of potential drug-drug interactions in chronic kidney disease patients: results from a retrospective analysis.Integrated pharmacy research & practice · 2017
   Article
9. Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children.Clinical pharmacokinetics · 2015
   Review
10. Drug dosage adjustment in hospitalized patients with renal impairment at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.BMC nephrology · 2015
    Article
11. Antibiotics in dental practice: how justified are we.International dental journal · 2015
    Review
12. Awareness and current implementation of drug dosage adjustment by pharmacists in patients with chronic kidney disease in Japan: a web-based survey.BMC health services research · 2014
    Article
13. Medication-prescribing patterns of primary care physicians in chronic kidney disease.Clinical and experimental nephrology · 2014
    Article
14. A comparison between standard triple therapy and sequential therapy on eradication of Helicobacter pylori in uremic patients: A randomized clinical trial.Advanced biomedical research · 2014
    Article
15. Appropriateness of drug dose and frequency in patients with renal dysfunction in a tertiary care hospital: A cross-sectional study.Journal of pharmacy & bioallied sciences · 2013
    Article
16. Estimating renal function to reduce the risk of adverse drug reactions.Drug safety · 2012
    Review
17. A computerized provider order entry intervention for medication safety during acute kidney injury: a quality improvement report.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2010
    Article
18. Overdose rate of drugs requiring renal dose adjustment: data analysis of 4 years prescriptions at a tertiary teaching hospital.Journal of general internal medicine · 2008
    Article
19. Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.Clinical pharmacokinetics · 2004
    Review
20. Principles of opioid use in chronic noncancer pain.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2003
    Review

Corrections and comments

• Commented on by
  Safe drug prescribing.2002

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as